Ambit Biosciences Corporation (AMBI) was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company — as the stock is now up more than 45% since Aug 4, 2014.
The company has seen 2 positive estimate revisions in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead for Ambit Biosciences. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Ambit Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked medical stocks include Gilead Sciences Inc. (GILD), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment